Is LY-2835219 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use LY-2835219? Is LY-2835219 safe for nursing mother and child? Does LY-2835219 extracts into breast milk? Does LY-2835219 has any long term or short term side effects on infants? Can LY-2835219 influence milk supply or can LY-2835219 decrease milk supply in lactating mothers?
Answer by DrLact: About LY-2835219 usage in lactation
No information is available on the clinical use of LY-2835219 during breastfeeding. Because LY-2835219 and its metabolites are over 90% bound to plasma proteins, the amount in milk is likely to be low. However, the manufacturer recommends that breastfeeding be discontinued during LY-2835219 therapy and for 3 weeks after the final dose.
Alternate Drugs
Vincristine(Dangerous)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Thioguanine(Dangerous)
Tamoxifen(Dangerous)
Nilotinib(Unsafe)
Mitoxantrone(Dangerous)
Mercaptopurine(Safe)
Trastuzumab(Unsafe)
Docetaxel(Dangerous)
Hydroxyurea(Low Risk)
Etoposide(Dangerous)
Dactinomycin(Dangerous)
Nivolumab(Unsafe)
Ipilimumab(Unsafe)
Doxorubicin(Dangerous)
Imatinib(Unsafe)
Cladribine(Dangerous)
Gemcitabine(Dangerous)
Cetuximab(Unsafe)
Cyclophosphamide(Dangerous)
Vinblastine(Dangerous)
Carboplatin(Dangerous)
Cisplatin(Unsafe)
Bleomycin(Dangerous)
Azelaic Acid(Safe)
Paclitaxel(Dangerous)
Busulfan(Dangerous)
Vinorelbine(Dangerous)
Fluorouracil(Dangerous)
Dacarbazine(Dangerous)
Letrozole(Dangerous)
Alemtuzumab(Low Risk)
Exemestane(Dangerous)
Dasatinib(Unsafe)
Rituximab(Low Risk)
Bevacizumab(Low Risk)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Gemcitabine(Dangerous)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Allopurinol(Safe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Nilotinib(Unsafe)